Japan Tobacco, Inc. engages in the manufacture and sale of tobacco, pharmaceutical and processed food products. It operates through the following divisions: Japanese Domestic Tobacco, International Tobacco, Pharmaceutical, and Processed Food. The Japanese Domestic segment deals with the production and sale of tobacco products in domestic areas. The International Tobacco segment manufactures and markets tobacco products worldwide. The Pharmaceutical segment develops, manufactures, and sells prescription drugs. The Processed Food segment offers processed food, bakery products and seasonings. The company was founded on April 1, 1985 and is headquartered in Tokyo, Japan.

Manufactures scientific instruments

Dongguan New Energy Technology Co., Ltd., established on 2004-05-24, Business scope includes development,Production and sales of high-tech green batteries,Lithium Ion Battery,lithium polymer battery,The fuel cell,Power Battery,Raw materials for supercapacitors and the above-mentioned batteries,Accessories,Semi-finished products and functional module products with the above-mentioned battery as the core unit(The above items do not involve hazardous chemicals);Sales of special machinery and general machinery,Precision Mold,Precision Injection Molded Parts,Instrumentation,Power management system and software,New electronic components and accessories;sales software,Hardware and Computer Systems;sell metal products,Glass product,plastic products;And provide after-sales service for the above products;Import and export of goods or technology(Except for the import and export of goods and technologies that are prohibited by the state or involve administrative approval).(The above projects do not involve special management measures for foreign investment access)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Diagnosis and Treatment businesses; Connected Care businesses; Personal Health businesses; and Other. The Diagnosis and Treatment businesses segment consists systems, smart devices, software and services, powered by AI-enabled informatics-that support precision diagnoses and minimally invasive procedures in therapeutic areas such as cardiology, peripheral vascular, neurology, surgery, and oncology. The Connected Care businesses segment consists Hospital Patient Monitoring, Emergency Care, Sleep & Respiratory Care and Connected Care Informatics. The Personal Health businesses segment consists of Oral Healthcare, Personal Care,Mother and Child Care. The Other segment reports on the items Innovation & Strategy, IP Royalties, Central costs, and other small items. The company was founded by Anton Frederik Philips and Gerard Leonard Frederik Philips in 1891 and is headquartered in Amsterdam, the Netherlands.

Meixin Testing Technology Co., Ltd. (doing business as US letter detection) is a Chinese private company located in Shenzhen with domestic subsidiaries. The firm provides electronic, plastic and metal materials & components quality inspection, identification, certification and failure analysis services. It was founded in 2012. Zhen Ying Yang is the current CEO of the company.\nThe company says this about itself: Meixin Testing Technology Co., Ltd is a commercial laboratory with CNAS and CMA approval certificate, committing to provide customers with material quality inspection, identification, certification and failure analysis and other professional and technical services. The services involve electronic appliances, new materials, new energy, automotive, civil aviation, education and scientific research and other industries. Meixin testing founded in 2012 and separately set up multiple detection and analysis laboratory in Shenzhen and Suzhou including microscopic analysis, thermal analysis, nondestructive testing, chemical composition, physical properties, reliability, and other detection and analysis laboratory. With scientific testing methods, professional engineers and sophisticated equipment, we help customers solve various engineering, scientific and technical problems in the product research and development, production, trade and other aspects.

Beijing Kangren Tang Pharmaceutical Co., Ltd. specializes in the research and production of particles more than 20 years of Chinese medicine formulations, stick formulations reforms to Chinese medicine theory as the foundation of traditional Chinese medicine decoction, formation and improve the "Ingredients ® " the formulation of reform ideas. In the "Ingredients ® experienced under the guidance of" the idea of 20-year study, completed the "Ingredients ® " production technology system and quality standard system of Chinese medicine formulations particles, was patented more than 40 in the process, laid the Beijing Conran Tang Pharmaceutical has the corporate characteristics of “Inheriting the essence of Chinese medicine culture and enjoying the innovation of Chinese medicine technology”.

Ningde New Energy Technology Co., Ltd., established on 2008-03-14, Business scope includes general items:battery manufacturing;battery sales;Manufacturing of capacitors and their supporting equipment;Sales of capacitors and related equipment;Manufacturing of electronic components and electromechanical components;Electronic special equipment manufacturing;Electronic special material manufacturing;Sales of electronic special equipment;Sales of electronic components and electromechanical components;Research and development of special electronic materials;Wholesale of electronic components;Electronic Components Retail;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Machinery sales;Mechanical Parts,Parts sales;Mold Sales;Instrument sales;Motor and its control system research and development;Industrial automatic control system device sales;software sales;Retailing of computer software, hardware and auxiliary equipment;Wholesale of computer software, hardware and auxiliary equipment;Optical communication equipment sales;Information security equipment sales;Internet equipment sales;Network Equipment Sales;Cloud Computing Equipment Sales;Metal Products Sales;Sales of daily glass products;Sales of plastic products;Sales of furniture spare parts;Intelligent storage equipment sales;Fire Equipment Sales;Sales of special labor protection products(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license) licensed items:Import and export;Technology Import and Export(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

Siemens AG is a technology company, which engages in the areas of automation and digitalization in the process and manufacturing industries, infrastructure for buildings and energy systems, mobility solutions for rail transport, and medical technology and digital healthcare services. It operates through the following segments: Digital Industries, Smart Infrastructure, Mobility, Siemens Healthineers, and Siemens Financial Services. The Digital Industries segment offers a product portfolio and system solutions for automation used in discrete and process industries. The Smart Infrastructure segment includes products, systems, solutions, services and software to support a transition from fossil to renewable energy sources. The Mobility segment combines all Siemens businesses in the area of passenger and freight transportation. The Siemens Healthineers segment develops, manufactures, and sells diagnostic and therapeutic products, and services to healthcare providers. The Siemens Financial Services segment focuses on financing solutions for Siemens’ customers as well as other companies in the form of debt and equity investments. The company was founded by Johann Georg Halske and Werner von Siemens on October 12, 1847 and is headquartered in Munich, Germany.

Hayashibara Co. Ltd. manufactures and develops starch syrups. It offers various food ingredients, such as maltose, hydrogenated glucose syrup, and various oligosaccharides. The company was founded in 1883 and is based in Okayama, Japan

Fuyu (Zhangjiagang) New Material Technology Co., Ltd., established on 2014-06-27, Business scope includes research and development,production catalyst,Sell ​​self-produced products and provide related after-sales services(Can only be operated after relevant approvals are processed);High-tech materials,energy,Technical services in the field of environmental protection materials technology,technical consulting,technology transfer,technology development;Electrical Equipment,Equipment,Chemical raw materials and products(Excluding hazardous chemicals)promotion of,Self-operated and agent import and export business of various commodities and technologies(Except for commodities and technologies that the state restricts the company to operate or prohibits the import and export of).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

PetroChina Co. Ltd. engages in the petroleum related products, services and activities. It operates through the following business segments: Exploration and Production; Refining and Chemicals; Marketing; Natural Gas and Pipeline; and Head Office and Other. The Exploration and Production segment involves exploration, development, production, and marketing of crude oil and natural gas. The Refining and Chemicals segment focuses on the refining of crude oil and petroleum products, production and marketing of primary petrochemical products, derivative petrochemical products, and other chemical products. The Marketing segment includes marketing of refined products and the trading business. The Natural Gas and Pipeline segment comprises transmission of natural gas, crude oil, and refined products and the sale of natural gas. The Head Office and Other segment relates to cash management and financing activities, the corporate center, research and development, and other business services supporting the operating business segments of the Group. The company was founded on November 5, 1999 and is headquartered in Beijing, China.

Harbin Labotong Pharmaceutical Co., Ltd., established on 2010-12-24, Business scope includes production:small volume injection(anticancer drug),powder injection,Freeze-dried powder injection(anticancer drug),tablet,API,Sterile API***(The drug production license is valid until2025year12moon31day);Food production and operation;Production and Operation of Medical Devices;Import and export,Technology Import and Export;Pharmaceutical Technology Development,Technical testing service(National law,Administrative regulations,Except for projects that require pre-approval as determined by the State Council);Drug Wholesale;Drug retail.

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products, including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Develops drugs for the treatment of cardiovascular and metabolic diseases

Daiichi Pharmaceutical Co. Ltd. manufactured pharmaceutical products. It used to make prescription drugs, OTC treatments and animal health products. The firm's prescription drugs included treatments for allergies, hypertension and stroke; it also has drugs in clinical trials. It was founded in 1915 and was located in Tokyo, Japan.

Shanghai Huatuo Pharmaceutical Technology Development Co. Ltd. is a Chinese private company located in Huangpu that engages in research and development, manufacturing and selling of pharmaceutical products.

Eli Lilly engages in the discovery, development, manufacture, and sale of products in the pharmaceutical products business segment. The company manufactures and distributes products through owned or leased facilities in the United States, Puerto Rico, and 25 other countries. Its products are sold in approximately 135 countries. It also conducts research to find products to treat diseases in animals and to increase the efficiency of animal food production.